ABC
BPMC

Associated Banc-Corp’s Blueprint Medicines BPMC Stock Holding History

Associated Banc-Corp’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-36
Closed -$4K – 373
2020
Q4 		$4K Hold
36
– – ﹤0.01% 530
2020
Q3 		$3K Hold
36
– – ﹤0.01% 520
2020
Q2 		$3K Hold
36
– – ﹤0.01% 492
2020
Q1 		$2K Buy
+36
New +$2.32K ﹤0.01% 531

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Associated Banc-Corp's BPMC Position: Q1 2021 in Review

Associated Banc-Corp sold out of Blueprint Medicines (BPMC) in Q1 2021, closing a stake of 36 shares — an estimated $4K sold.

Associated Banc-Corp first reported a position in BPMC in Q1 2020 and held it in 4 quarters. The position peaked at $4K in Q4 2020. 263 funds tracked by Wall St. Rank hold BPMC as of Q1 2021.

  • Associated Banc-Corp reported no remaining Blueprint Medicines position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 36 Blueprint Medicines shares in Q1 2021, an estimated $4K.
  • Associated Banc-Corp first reported a position in Blueprint Medicines in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Blueprint Medicines position peaked at $4K in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.